Hilal Eren Gözel

Scholarly Output Search Results

Now showing 1 - 1 of 1

Citation Count: 0
LDH-A Inhibitor as a Remedy to Potentiate the Anticancer Effect of Docetaxel in Prostate Cancer
(Ivyspring int Publ, 2024) Cakici, Cagri; Daylan, Benay; Unluer, Ruveyde Safiye; Emekli-Alturfan, Ebru; Ayla, Sule; Gozel, Hilal Eren; Yigitbasi, Turkan; Tıbbi Biyoloji Anabilim Dalı / Department of Medical Biology
Increased LDH-A activity promotes tumor growth, migration, invasion, and metastasis. This study aimed to investigate the effects of the combination of LDH-A inhibitor and Docetaxel on apoptosis and epithelial-mesenchymal transition (EMT) in the murine prostate cancer (PCa) model. The prostate cancer murine model was developed subcutaneously in 50 male B57CL/6 mice using the Tramp -C2 prostate cancer cell line. From the tumor tissue samples, apoptosis analysis was performed using TUNEL staining, and EMT was investigated using western blot and qPCR. Hematoxylin-eosin staining (HE) and Periodic acid-Schiff staining were used to histopathologically examine liver and kidney tissues. Lactate levels revealed that the Warburg effect was reversed with the LDH-A inhibitor. Both serum and tumor tissue apoptosis increased, and tumor sizes reduced in PCa+LDH-A inhibitor + Docetaxel treatment groups (p<0.05). The combination of LDH-A inhibitor and Docetaxel inhibited EMT mechanism by causing a decrease in Snail, Slug, Twist, and HIF-1 alpha expressions as well as a decrease in N-cadherin and an increase in E-cadherin levels. Reprogramming glucose metabolism with an LDH-A inhibitor can increase the effectiveness of Docetaxel on apoptosis and metastasis mechanisms in PCa.

Eren Gözel, Hilal

Name Variants

Job Title

Email Address

ORCID ID

Scopus Author ID

Turkish CoHE Profile ID

Google Scholar ID

WoS Researcher ID

Scholarly Output

1

Articles

1

Citation Count

0

Supervised Theses

0

Filters

Settings

Sort By

Results per page

Scholarly Output Search Results